Javier Corral is an Oncology physician affiliated with Texas Tech University. OpenAlex indexes 349 publications with 7,956 citations (h-index 44).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4801 Alberta Ave.
El Paso, TX 79905
Telephone
915-545-6626Provider last certified this registry record 16 Sept 2021.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20257 payments
- E.R. Squibb & Sons, L.L.C.Program year20259 payments
- Merck Sharp & Dohme LLCProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.3%Kinase inhibitor19.9%Jakafi30%Imatinib Mesylate18%Inlyta17%Sprycel13%Alecensa11%Lenvima11%Part D<11 patientsAndrogen Receptor Inhibitor7.7%Xtandi100%Part D<11 patients+ 4 more classes in this area
Nervous system
30.4%Opioid Agonist15.1%Fentanyl49%Oxycodone Hcl26%Tramadol Hcl25%Part D<11 patientsPhenothiazine7.7%Prochlorperazine Maleate100%Part D≥24 patients+ 2 more classes in this area
Respiratory
14.6%Opioid Agonist14.6%Hydrocodone-Acetaminophen100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Scalable production of tissue-like vascularized liver organoids from human PSCs
Experimental & Molecular Medicine
2023 - Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients
Scientific Reports
2021 - International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up
Journal of Inherited Metabolic Disease
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Debabrata Mukherjee, MD
Texas Tech University
Ariwan Rakvit, MD
Texas Tech University
Kenneth Nugent, MD
Texas Tech University
Marc Zuckerman, MD
Texas Tech University
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”